Characterization, Stability, and In Vivo Efficacy Studies of Recombinant Human CNTF and Its Permeation into the Neural Retina in Ex Vivo Organotypic Retinal Explant Culture Models

被引:10
作者
Itkonen, Jaakko [1 ]
Annala, Ada [2 ,3 ]
Tavakoli, Shirin [1 ]
Arango-Gonzalez, Blanca [4 ]
Ueffing, Marius [4 ]
Toropainen, Elisa [2 ]
Ruponen, Marika [2 ]
Casteleijn, Marco G. [1 ,5 ]
Urtti, Arto [1 ,2 ,6 ]
机构
[1] Univ Helsinki, Fac Pharm, Drug Res Program, Viikinkaari 5 E, Helsinki 00790, Finland
[2] Univ Eastern Finland, Sch Pharm, Yliopistonranta 1, Kuopio 70211, Finland
[3] Univ Utrecht, Utrecht Inst Pharmaceut Sci, David Wiedgebouw,Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[4] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Elfriede Aulhorn Str 7, D-72076 Tubingen, Germany
[5] VTT Tech Res Ctr Finland Ltd, Solut Nat Resources & Environm, VTT, Tietotie 2,POB 1000, FI-02044 Espoo, Finland
[6] St Petersburg State Univ, Inst Chem, Lab Biohybrid Technol, Univ Skii Pr 26, St Petersburg 198504, Russia
基金
芬兰科学院;
关键词
retinal penetration; neuroprotection; protein aggregation; stability; intravitreal delivery; CNTF; CILIARY NEUROTROPHIC FACTOR; INTRAOCULAR GENE-TRANSFER; GANGLION-CELL SURVIVAL; INTRAVITREAL INJECTION; MOUSE-MODEL; PHOTORECEPTOR SURVIVAL; INTERLEUKIN-6; RECEPTOR; PROTEIN STABILITY; DRUG STABILITY; OUTER SEGMENTS;
D O I
10.3390/pharmaceutics12070611
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ciliary neurotrophic factor (CNTF) is one of the most studied neuroprotective agents with acknowledged potential in treating diseases of the posterior eye segment. Although its efficacy and mechanisms of action in the retina have been studied extensively, it is still not comprehensively understood which retinal cells mediate the therapeutic effects of CNTF. As with therapeutic proteins in general, it is poorly elucidated whether exogenous CNTF administered into the vitreous can enter and distribute into the retina and hence reach potentially responsive target cells. Here, we have characterized our purified recombinant human CNTF (rhCNTF), studied the protein's in vitro bioactivity in a cell-based assay, and evaluated the thermodynamic and oligomeric status of the protein during storage. Biological activity of rhCNTF was further evaluated in vivo in an animal model of retinal degeneration. The retinal penetration and distribution of rhCNTF after 24 h was studied utilizing two ex vivo retina models. Based on our characterization findings, our rhCNTF is correctly folded and biologically active. Moreover, based on initial screening and subsequent follow-up, we identified two buffers in which rhCNTF retains its stability during storage. Whereas rhCNTF did not show photoreceptor preservative effect or improve the function of photoreceptors in vivo, this could possibly be due to the used disease model or the short duration of action with a single intravitreal injection of rhCNTF. On the other hand, the lack of in vivo efficacy was shown to not be due to distribution limitations; permeation into the retina was observed in both retinal explant models as in 24 h rhCNTF penetrated the inner limiting membrane, and being mostly observed in the ganglion cell layer, distributed to different layers of the neural retina. As rhCNTF can reach deeper retinal layers, in general, having direct effects on resident CNTF-responsive target cells is plausible.
引用
收藏
页码:1 / 31
页数:30
相关论文
共 109 条
[71]   Ciliary neurotrophic factor (CNTF): New facets of an old molecule for treating neurodegenerative and metabolic syndrome pathologies [J].
Pasquin, Sarah ;
Sharma, Mukut ;
Gauchat, Jean-Francois .
CYTOKINE & GROWTH FACTOR REVIEWS, 2015, 26 (05) :507-515
[72]   Prediction of intraocular antibody drug stability using ex-vivo ocular model [J].
Patel, Sulabh ;
Stracke, Jan Olaf ;
Altenburger, Ulrike ;
Mahler, Hanns-Christian ;
Metzger, Philipp ;
Shende, Pankaj ;
Jere, Dhananjay .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 112 :177-186
[73]   Evaluation of protein drug stability with vitreous humor in a novel ex-vivo intraocular model [J].
Patel, Sulabh ;
Mueller, Gerd ;
Stracke, Jan Olaf ;
Altenburger, Ulrike ;
Mahler, Hanns-Christian ;
Jere, Dhananjay .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 95 :407-417
[74]   Effect of CNTF on Retinal Ganglion Cell Survival in Experimental Glaucoma [J].
Pease, Mary Ellen ;
Zack, Donald J. ;
Berlinicke, Cynthia ;
Bloom, Kristen ;
Cone, Frances ;
Wang, Yuxia ;
Klein, Ronald L. ;
Hauswirth, William W. ;
Quigley, Harry A. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (05) :2194-2200
[75]  
Peterson WM, 2000, J NEUROSCI, V20, P4081
[76]   Morphology and Composition of the Inner Limiting Membrane: Species-Specific Variations and Relevance toward Drug Delivery Research [J].
Peynshaert, Karen ;
Devoldere, Joke ;
Minnaert, An-Katrien ;
De Smedt, Stefaan C. ;
Remaut, Katrien .
CURRENT EYE RESEARCH, 2019, 44 (05) :465-475
[77]   In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye [J].
Peynshaert, Karen ;
Devoldere, Joke ;
De Smedt, Stefaan C. ;
Remaut, Katrien .
ADVANCED DRUG DELIVERY REVIEWS, 2018, 126 :44-57
[78]   Toward smart design of retinal drug carriers: a novel bovine retinal explant model to study the barrier role of the vitreoretinal interface [J].
Peynshaert, Karen ;
Devoldere, Joke ;
Forster, Valerie ;
Picaud, Serge ;
Vanhove, Christian ;
De Smedt, Stefaan C. ;
Remaut, Katrien .
DRUG DELIVERY, 2017, 24 (01) :1384-1394
[79]   QUANTITATION OF 5-BROMO-2-DEOXYURIDINE INCORPORATION INTO DNA - AN ENZYME-IMMUNOASSAY FOR THE ASSESSMENT OF THE LYMPHOID-CELL PROLIFERATIVE RESPONSE [J].
PORSTMANN, T ;
TERNYNCK, T ;
AVRAMEAS, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 82 (01) :169-179
[80]   CNTF-mediated protection of photoreceptors requires initial activation of the cytokine receptor gp130 in Muller glial cells [J].
Rhee, Kun Do ;
Nusinowitz, Steven ;
Chao, Kevin ;
Yu, Fei ;
Bok, Dean ;
Yang, Xian-Jie .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (47) :E4520-E4529